APPENDIX 1
Letter to the Clerk of the Committee from
Mr Martin Gagen, Head of UK Investment, 3i Group plc
Thank you for your letter of 15 December asking
whether we would like to submit a supplementary memorandum to
the committee by the end of January.
We responded to your initial invitation to produce
evidence to your committee because we are firmly committed to
investing in and supporting the growth of promising technology-based
businesses. Since giving evidence, our support has continued to
grow and we have expanded our own programme of research into ways
of creating more such companies and supporting them more effectively.
I would like to highlight some of that ongoing work here:
1. Capital Gains Tax. The debate
about encouraging innovation and new business creation now recognises
the complex nature of the issues and the difficulty of creating
rapid cultural change that is durable. In our view the capital
gains tax rate is the only simple lever available for catalysing
change that has been identified and proven elsewhere. The evidence
shows that where countries have reduced CGT to materially lower
levels than in the UK, there has been a major beneficial impact
in new business creation. Furthermore it is increasingly evident
that the best entrepreneurs are geographically mobile and that
the UK needs to measure its CGT rates against international yardsticks.
We attach a Budget submission for 1999-2000
that summarises our views1.
2. Corporate Venturing. Since
our submission to the Committee, we have seen increasing activity
by large corporates in "venturing" and investing in
interesting technology businesses. We now have close relationships
with several such international businesses and one has already
made a number of investments alongside us. Workable models of
corporate venturing have been rare, both internationally and in
the United Kingdom.
We could be witnessing, however, the beginning
of a sea-change in corporate attitudes, driven largely by the
increasing difficulty faced by in-house research groups in keeping
abreast of technology developments globally. In consequence, we
are sponsoring research into the area by the Judge Institute in
Cambridge and expect their initial output this summer. If the
Committee is still sitting then, we would be pleased to provide
relevant information.
3. "University Challenge" We
continue to be actively involved in seed funding and keen to ensure
the success of projects such as "University Challenge".
We have expressed our views on this subject to the Committee and
elsewhere before but, in brief, we remain concerned that such
funds should be concentrated, with sufficient critical mass, on
excellence. One key issue, for example, is that any fund be of
sufficient size to attract a seasoned individual as its manager/investor.
Another is that the resources go to those situations that have
the real potential to be large businesses. In this way, public
money is more likely to stimulate successful projects which attract
private sector management and investment. The sincerity of our
views is reflected in our substantial recent investments in seed
funds such as the Medical Research Council Fund and Cambridge's
Quantum Fund.
4. The European New Issues Markets. One
of the key ingredients in encouraging the venture capital industry
to support young technology companies is the ready availability
of later-stage support from stock markets. Since 1995 a number
of new stock markets have been created in Europe, which is encouraging.
On the other hand a number of more recent developments are reducing
the markets willingness to support promising companies. In view
of this complex picture we have sponsored research at Insead,
where we have ongoing sponsorship of the "3i Venturelab",
into the European New Issues Market. A copy of the preliminary
review is attached[1].
I would like to thank the Committee for the
opportunity to contribute to this important Inquiry. 3i is happy
to provide any further assistance at any time.
September 1998
1 Not printed. Back
|